5 completed, 3 unknown, 2 active not recruiting, 2 withdrawn. 5 Not applicable, 4 Phase 2, 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 2, Withdrawn 2, Unknown 1 |
| Phase 2 | 4 | Active not recruiting 2, Completed 1, Unknown 1 |
| Early Phase 1 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Acoustic Neuroma: new trials by email Literature Review of Acoustic Neuroma trials Research Report on Acoustic Neuroma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures Panitumumab-IRDye800 - Meningioma, Glioblastoma | Early Phase 1 | Recruiting | Eben Rosenthal | 30 | 2026-07-07 | 2026-10-16 |
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases | Phase 2 | Completed | Reveal Pharmaceuticals Inc. | 18 | 2024-08-15 | 2025-12-26 |
| Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery Vestibular exam - Vestibular Schwannoma, Neurinoma, Acoustic | Not applicable | Unknown | Centre Hospitalier Universitaire de Besancon | 20 | 2024-02-20 | 2024-09-19 |
| Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma RAM-Based Nursing + RAM Follow-Up Care - Acoustic Neuroma, Facial Paralysis | Not applicable | Completed | West China Hospital | 160 | 2022-01-01 | 2025-12-26 |
| Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery Testing of Pre-Positioning Frame - Acoustic Neuroma | Not applicable | Withdrawn | Vanderbilt University Medical Center | 2021-12-01 | 2022-01-20 | |
| Auditory Nerve Test System During Vestibular Schwannoma Resection Auditory Nerve Test System - Vestibular Schwannoma, Acoustic Neuroma | Not applicable | Completed | Washington University School of Medicine | 10 | 2020-01-20 | 2024-04-25 |
| Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised Scale of quality life - Acoustic Neuroma | Unknown | University Hospital, Bordeaux | 200 | 2018-12-05 | 2019-07-02 | |
| Study of Aspirin in Patients With Vestibular Schwannoma Aspirin, Placebo - Vestibular Schwannoma, Acoustic Neuroma | Phase 2 | Active not recruiting | Massachusetts Eye and Ear Infirmary | 97 | 2018-03-01 | 2026-10-16 |
| RGD PET/MRI in Sporadic Vestibular Schwannoma One injection of 68Ga-NODAGA-E[c(RGDyK)]2 - Acoustic Neuroma | Phase 2 | Unknown | Copenhagen University Hospital, Rigshospitalet | 40 | 2018-01-02 | 2018-01-10 |
| Maintaining Cochlear Patency After VIIIth Nerve Surgery MedEl Test Electrode Placer - Acoustic Neuroma, Labyrinthitis Ossificans | Not applicable | Withdrawn | Henry Ford Health System | 2017-08-04 | 2025-12-19 | |
| WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data Whole exome sequencing - Neurofibromatosis Type 2, Vestibular Schwannoma | Completed | University Hospital Tuebingen | 70 | 2017-07-31 | 2018-07-23 | |
| Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma AR-42 - Vestibular Schwannoma, Meningioma | Early Phase 1 | Terminated | Massachusetts Eye and Ear Infirmary | 7 | 2015-12-01 | 2026-10-28 |
| Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma Fractionated proton radiation, Losartan - Vestibular Schwannoma, Acoustic Neuroma | Phase 2 | Active not recruiting | Massachusetts General Hospital | 30 | 2011-03-08 | 2026-09-11 |
| Concentration and Activity of Lapatinib in Vestibular Schwannomas lapatinib - Vestibular Schwannoma, NF2 | Early Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 26 | 2009-06-01 | 2021-01-12 |
Neuroma, Acoustic (14) · Neurofibromatosis 2 (4) · Meningioma (3) · Neurilemmoma (3) · Brain Neoplasms (2) · Neoplasms (2) · Central Nervous System Neoplasms (1) · Facial Paralysis (1) · Glioblastoma (1) · Glioma (1) · Hearing Loss, Sensorineural (1) · Hearing Loss, Unilateral (1) · Multiple Sclerosis (1) · Neurofibroma (1) · Neuroinflammatory Diseases (1)
Cranial Nerve Diseases (14) · Cranial Nerve Neoplasms (14) · Ear Diseases (14) · Neoplasms by Histologic Type (14) · Neoplasms by Site (14) · Neoplasms, Germ Cell and Embryonal (14) · Neoplasms, Nerve Tissue (14) · Nerve Sheath Neoplasms (14) · Nervous System Diseases (14) · Nervous System Neoplasms (14) · Neuroectodermal Tumors (14) · Neuroendocrine Tumors (14) · Neuroma (14) · Otorhinolaryngologic Diseases (14) · Otorhinolaryngologic Neoplasms (14)
Aspirin (1) · Exome (1) · HDAC-42 (1) · Lapatinib (1) · Losartan (1) · Mn-PyC3A (1)
Massachusetts Eye and Ear Infirmary (2) · Centre Hospitalier Universitaire de Besancon (1) · Copenhagen University Hospital, Rigshospitalet (1) · Eben Rosenthal (1) · Henry Ford Health System (1) · Massachusetts General Hospital (1) · Reveal Pharmaceuticals Inc. (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · University Hospital Tuebingen (1) · University Hospital, Bordeaux (1) · Vanderbilt University Medical Center (1) · Washington University School of Medicine (1) · West China Hospital (1)
United States (9) · France (2) · China (1) · Denmark (1) · Germany (1)
Brad Welling, MD, PhD (1) · Cameron C Wick, MD (1) · D. Bradley Welling, MD, PhD (1) · Eric W Sargent, MD (1) · Helen A. Shih, MD (1) · Hjalte C.R. Sass, MD, Ph.d.-Fellow (1) · Jaishri O Blakeley, MD (1) · Konstantina Stankovic, MD, PhD (1) · Martin Schuhmann, Prof. Dr. (1) · Peter Morone, MD (1) · Robert F. Labadie, MD, PhD (1) · Robert J. Webster, PhD (1)
PMID 26943915, PMID 34667843, PMID 35229827, PMID 41530428
2017 (1), R01DC012593 (1), R44CA261240 (1)